SSKN vs. VVOS, NXL, COCH, NXGL, XAIR, FEMY, IRIX, BTCY, ICU, and HSDT
Should you be buying Strata Skin Sciences stock or one of its competitors? The main competitors of Strata Skin Sciences include Vivos Therapeutics (VVOS), Nexalin Technology (NXL), Envoy Medical (COCH), NexGel (NXGL), Beyond Air (XAIR), Femasys (FEMY), IRIDEX (IRIX), Biotricity (BTCY), SeaStar Medical (ICU), and Solana (HSDT). These companies are all part of the "medical equipment" industry.
Strata Skin Sciences vs. Its Competitors
Vivos Therapeutics (NASDAQ:VVOS) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment.
26.4% of Vivos Therapeutics shares are held by institutional investors. Comparatively, 32.4% of Strata Skin Sciences shares are held by institutional investors. 2.1% of Vivos Therapeutics shares are held by insiders. Comparatively, 39.0% of Strata Skin Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Vivos Therapeutics presently has a consensus target price of $4.92, indicating a potential upside of 72.51%. Strata Skin Sciences has a consensus target price of $6.00, indicating a potential upside of 210.88%. Given Strata Skin Sciences' higher probable upside, analysts clearly believe Strata Skin Sciences is more favorable than Vivos Therapeutics.
Strata Skin Sciences has a net margin of -35.13% compared to Vivos Therapeutics' net margin of -99.49%. Vivos Therapeutics' return on equity of -232.76% beat Strata Skin Sciences' return on equity.
Strata Skin Sciences has higher revenue and earnings than Vivos Therapeutics. Vivos Therapeutics is trading at a lower price-to-earnings ratio than Strata Skin Sciences, indicating that it is currently the more affordable of the two stocks.
Vivos Therapeutics has a beta of 6.9, meaning that its share price is 590% more volatile than the S&P 500. Comparatively, Strata Skin Sciences has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500.
In the previous week, Strata Skin Sciences had 5 more articles in the media than Vivos Therapeutics. MarketBeat recorded 7 mentions for Strata Skin Sciences and 2 mentions for Vivos Therapeutics. Strata Skin Sciences' average media sentiment score of -0.08 beat Vivos Therapeutics' score of -1.00 indicating that Strata Skin Sciences is being referred to more favorably in the news media.
Summary
Strata Skin Sciences beats Vivos Therapeutics on 10 of the 14 factors compared between the two stocks.
Get Strata Skin Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for SSKN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SSKN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Strata Skin Sciences Competitors List
Related Companies and Tools
This page (NASDAQ:SSKN) was last updated on 10/20/2025 by MarketBeat.com Staff
